Clincosm LogoSign in Get a demo

everolimus

Showing 1 - 5 of 5
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Everolimus-containing Chemotherapy in HER2- mBC PI3K/AKT/mTOR

Completed
  • Breast Cancer
  • +2 more
  • No intervention, it was a retrospective study.
  • Hangzhou, Zhejiang, China
    Zhejiang Cancer Hospital
Sep 13, 2021

Everolimus Related Pneumonitis in MBC

Completed
  • Everolimus
  • Pneumonitis
    • Shanghai, Shanghai, China
      Fudan University Shanghai Cancer Center
    Aug 16, 2020

    Neuroendocrine Tumors, Everolimus Trial in Lexington (everolimus, fosbretabulin)

    Terminated
    • Neuroendocrine Tumors
    • Everolimus
    • Lexington, Kentucky
      University of Kentucky Markey Cancer Center
    Aug 6, 2019

    Renal Impairment, Liver Transplantation, Everolimus Trial in Regensburg (delayed, low-dose CNI, BU-CNI, BU-Everolimus)

    Unknown status
    • Renal Impairment
    • +2 more
    • delayed, low-dose CNI
    • +2 more
    • Regensburg, Bavaria, Germany
      Regensburg University Hospital
    Jun 30, 2011

    Coronary Artery Disease, Everolimus, Vascular Disease Trial in Denmark, Germany, Netherlands (Coronary artery drug eluting stent

    Completed
    • Coronary Artery Disease
    • +4 more
    • Coronary artery drug eluting stent placement
    • Coronary artery stent placement
    • Aarhus, Denmark
    • +6 more
    Jan 5, 2010